RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue
RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue
Recruiting · NCT06739720 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue | Chronic Disease, Disease Attributes, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, encephalomyelitis, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, neuromuscular disease | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT06739720 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovation and Technology Commission, Hong Kong | 4 |
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Specialist Clinical Centre for Teaching and Research, School of Chinese Medicine, The University of Hong Kong | Hong Kong | Hong Kong | 1 |